---
title: "Understanding the Market | GRANDPHARMA rose over 6% in the morning as the new myopia drug GPN00884 recently started its Phase IIa clinical trial in China"
description: "GRANDPHARMA rose over 6% in the morning, and as of the time of writing, it has increased by 6.42%, trading at HKD 8.79, with a transaction volume of HKD 101 million. In terms of news, GRANDPHARMA rece"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263937574.md"
published_at: "2025-11-03T03:59:51.000Z"
---

# Understanding the Market | GRANDPHARMA rose over 6% in the morning as the new myopia drug GPN00884 recently started its Phase IIa clinical trial in China

> GRANDPHARMA rose over 6% in the morning, and as of the time of writing, it has increased by 6.42%, trading at HKD 8.79, with a transaction volume of HKD 101 million. In terms of news, GRANDPHARMA recently announced that the global innovative ophthalmic drug GPN00884, used to delay the progression of myopia in children, has completed the enrollment and dosing of the first patient in its Phase IIa clinical study in China. This means that GPN00884 will enter an important phase to explore drug dosage and assess preliminary efficacy. If the expected drug effectiveness is successfully realized, clinical practice may welcome a new solution for alleviating the progression of myopia in children. It is worth noting that in July of this year, the oxymetazoline hydrochloride nasal spray (OC-01) was launched in mainland China, revolutionizing the treatment experience for dry eye patients through nasal spray. Recently, GRANDPHARMA successfully held a national launch conference for OC-01, taking advantage of the 11th Global Dry Eye Academic Conference themed "Caring for Dry Eye Patients, Welcoming the Era of Native Tears - 2025 New Advances in Dry Eye Diagnosis and Treatment and the Construction of Ocular Surface Health Ecology," officially announcing the arrival of a new era in dry eye treatment from "external replacement" to "internal awakening."

According to Zhitong Finance APP, GRANDPHARMA (00512) rose over 6% in the morning, and as of the time of publication, it increased by 6.42%, reaching HKD 8.79, with a transaction volume of HKD 101 million.

In terms of news, GRANDPHARMA recently announced that the global innovative ophthalmic drug GPN00884, used to delay the progression of myopia in children, has completed the enrollment and administration of the first patient in the Phase IIa clinical study conducted in China. This means that GPN00884 will enter an important stage of exploring drug dosage and assessing preliminary efficacy. If the expected drug effectiveness is successfully realized, a new solution for alleviating the progression of myopia in children may emerge in clinical practice.

It is worth noting that in July of this year, the oxymetazoline hydrochloride nasal spray (OC-01) was launched in mainland China, revolutionizing the treatment experience for dry eye patients through nasal spray. Recently, GRANDPHARMA successfully held a national launch conference for OC-01, taking advantage of the 11th Global Dry Eye Academic Conference themed "Caring for Dry Eye Patients, Welcoming the Era of Native Tears - New Advances in Dry Eye Diagnosis and Treatment and the Construction of Ocular Surface Health Ecology 2025," officially announcing the arrival of a new era in dry eye treatment from "external replacement" to "internal awakening."

### Related Stocks

- [00512.HK - GRANDPHARMA](https://longbridge.com/en/quote/00512.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 07:05 ETHearing Loss in Children: ASHA, EAA Stress Importance of Prevention and Early Intervention This World Hearing Day | On World Hearing Day, the American Speech-Language-Hearing Association (ASHA) and the Educational Audiology Association  | [Link](https://longbridge.com/en/news/276729927.md) |
| Is It Time To Reopen The Franklin Child Prostitution Case After Epstein Revelations? | The article discusses the potential reopening of the Franklin Child Prostitution Case in light of new revelations from t | [Link](https://longbridge.com/en/news/276503065.md) |
| VA reverses on new disability rating rule after intense backlash | The Department of Veterans Affairs (VA) has reversed a controversial rule that calculated veterans' disability ratings b | [Link](https://longbridge.com/en/news/276476721.md) |
| Movers’ Quick Action Helped Police Rescue 3-Year-Old Allegedly Kidnapped By ‘Random Woman’ | A 3-year-old girl from Arizona, Kehlani Rogers, was rescued after being allegedly kidnapped by a woman her parents had a | [Link](https://longbridge.com/en/news/276771603.md) |
| ZAWYA-PRESSR: ECA and Hub71 open applications for Anjal Z to accelerate global early childhood innovation in Abu Dhabi | The Abu Dhabi Early Childhood Authority (ECA) and Hub71 have opened applications for the 2026 Cohort of Anjal Z, a fello | [Link](https://longbridge.com/en/news/276314981.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.